Conexeu Sciences, Inc. (CNXU)
3.10
-0.22
(-6.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.14
+0.04
(+1.29%)
After-Hours: 20:00
Conexeu Sciences Debt to Equity Ratio : 0.0124 for July 31, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| July 31, 2026 | 0.0124 |
| April 30, 2026 | 0.00 |
| January 31, 2026 |
| Date | Value |
|---|---|
| October 31, 2025 | |
| April 30, 2025 | |
| October 31, 2024 | 1.033 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AbbVie, Inc. | -11.93 |
| Vericel Corp. | 0.2556 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Savara, Inc. | 0.2117 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.156M |
| Total Liabilities (Quarterly) | 1.306M |
| Shareholders Equity (Quarterly) | 5.850M |
| Current Ratio | 5.310 |
| Net Debt Paydown Yield | 0.00% |